Now, however, researchers say that the JUPITER results are flawed -- and that they do not support the benefits initially reported.:
Now, however, researchers say that the JUPITER results are flawed -- and that they do not support the benefits initially reported.
Not only is there no "striking decrease in coronary heart disease complications", but a new report has also called into question drug companies' involvement in such trials. ABC News reports::
Not only is there no "striking decrease in coronary heart disease complications", but a new report has also called into question drug companies' involvement in such trials. ABC News reports:
"... major discrepancies exists between the significant reductions in nonfatal stroke and heart attacks reported in the JUPITER trial and what has been found in other research ... 'The JUPITER data set appears biased,' [the researchers] wrote in conclusion.":
"... major discrepancies exists between the significant reductions in nonfatal stroke and heart attacks reported in the JUPITER trial and what has been found in other research ... 'The JUPITER data set appears biased,' [the researchers] wrote in conclusion."